D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PXD
276
DELISTED
Pioneer Natural Resource Co.
PXD
| $69.5M | 0.09% |
456,526
-350,124
| -43% | -$49.4M |
|
277
Qiagen
QGEN
$8.53B
| $69.4M | 0.09% |
1,609,974
-46,292
| -3% | -$1.86M |
|
278
NVIDIA
NVDA
$5.01T
| $69.4M | 0.09% |
15,457,040
+2,279,800
| +17% | +$8.85M |
|
279
Eaton
ETN
$157B
| $69.4M | 0.09% |
861,023
-9,464
| -1% | -$722K |
|
280
CALL
AutoZone
AZO
$48.3B
| $69M | 0.09% |
67,400
-5,200
| -7% | -$4.67M |
|
281
Western Union
WU
$2.57B
| $68.7M | 0.09% |
3,721,717
+1,893,934
| +104% | +$34.1M |
|
282
Brunswick
BC
$5.19B
| $67.7M | 0.09% |
1,344,423
-435,136
| -24% | -$21.9M |
|
283
Pediatrix Medical
MD
$2.16B
| $67.6M | 0.09% |
2,486,541
+1,215,631
| +96% | +$40.8M |
|
284
F5
FFIV
$22.1B
| $67.4M | 0.09% |
429,342
-37,951
| -8% | -$6.11M |
|
|
WRK
285
DELISTED
WestRock Company
WRK
| $67.2M | 0.09% |
1,752,839
+1,349,915
| +335% | +$52.8M |
|
286
Snap
SNAP
$7.32B
| $67.2M | 0.09% |
6,096,663
+5,899,414
| +2,991% | +$50.2M |
|
287
Healthpeak Properties
DOC
$15.4B
| $66.2M | 0.09% |
2,116,064
-1,371,758
| -39% | -$41.8M |
|
288
CALL
IBM
IBM
$202B
| $66M | 0.09% |
489,214
-125,939
| -20% | -$16.1M |
|
289
CALL
Verizon
VZ
$194B
| $66M | 0.09% |
1,115,500
-17,900
| -2% | -$1.01M |
|
290
Valero Energy
VLO
$89.8B
| $65.1M | 0.08% |
767,154
+565,198
| +280% | +$46.7M |
|
291
Johnson Controls International
JCI
$87.5B
| $64.7M | 0.08% |
1,752,481
-10,322
| -0.6% | -$354K |
|
292
Simon Property Group
SPG
$74.5B
| $64.7M | 0.08% |
354,943
-132,069
| -27% | -$23.5M |
|
293
Post Holdings
POST
$4.12B
| $64.5M | 0.08% |
901,127
-7,341
| -0.8% | -$481K |
|
294
CALL
Walt Disney
DIS
$165B
| $64.5M | 0.08% |
580,600
+471,900
| +434% | +$52.7M |
|
295
DexCom
DXCM
$27.6B
| $64M | 0.08% |
2,151,032
-564,496
| -21% | -$19.8M |
|
296
PUT
Eli Lilly
LLY
$1.07T
| $63.8M | 0.08% |
491,500
+363,400
| +284% | +$44.2M |
|
297
CALL
Boeing
BA
$165B
| $63.4M | 0.08% |
166,300
+3,800
| +2% | +$1.46M |
|
298
DuPont de Nemours
DD
$18.6B
| $62.8M | 0.08% |
465,521
-670,832
| -59% | -$93.1M |
|
|
HOLX
299
DELISTED
Hologic
HOLX
| $62.8M | 0.08% |
1,298,083
-451,181
| -26% | -$20.3M |
|
|
300
PUT
Bristol-Myers Squibb
BMY
$127B
| $62.8M | 0.08% |
1,315,400
+386,600
| +42% | +$19.3M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.